Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.350
-0.010 (-0.42%)
Nov 4, 2024, 4:00 PM EST - Market closed

Armata Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
85117451485632
Upgrade
Market Cap Growth
141.29%161.30%-69.80%165.90%72.90%-
Upgrade
Enterprise Value
205207591495327
Upgrade
Last Close Price
2.353.241.245.482.983.25
Upgrade
PE Ratio
--1.69-1.15-5.70-2.21-1.28
Upgrade
PS Ratio
22.8225.868.1433.1867.83-
Upgrade
PB Ratio
-2.16-3.651.245.842.962.21
Upgrade
P/FCF Ratio
-2.16-2.11-1.29-5.97-2.92-2.04
Upgrade
P/OCF Ratio
-2.58-2.47-1.38-6.30-3.06-2.07
Upgrade
EV/Sales Ratio
55.0645.6610.6933.2364.37-
Upgrade
EV/EBITDA Ratio
-5.61-5.18-1.63-6.56-2.59-1.61
Upgrade
EV/EBIT Ratio
-5.46-5.06-1.59-6.24-2.45-1.49
Upgrade
EV/FCF Ratio
-4.98-3.72-1.70-5.98-2.77-1.69
Upgrade
Debt / Equity Ratio
-3.17-3.751.351.500.700.20
Upgrade
Debt / FCF Ratio
-3.17-2.17-1.41-1.53-0.69-0.18
Upgrade
Asset Turnover
0.040.050.070.080.03-
Upgrade
Quick Ratio
0.221.030.942.761.521.24
Upgrade
Current Ratio
0.251.161.093.111.621.36
Upgrade
Return on Equity (ROE)
--3439.35%-120.10%-104.65%-132.62%-174.80%
Upgrade
Return on Assets (ROA)
-25.09%-26.32%-27.89%-27.25%-41.53%-56.22%
Upgrade
Return on Capital (ROIC)
-28.04%-29.51%-31.15%-31.22%-54.55%-89.41%
Upgrade
Earnings Yield
-78.85%-58.95%-82.37%-15.60%-39.73%-60.33%
Upgrade
FCF Yield
-54.19%-47.45%-77.40%-16.76%-34.20%-48.96%
Upgrade
Buyback Yield / Dilution
-0.15%-5.19%-42.27%-46.84%-104.93%-72.15%
Upgrade
Total Shareholder Return
-0.15%-5.19%-42.27%-46.84%-104.93%-72.15%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.